Taylor Jennifer L, Turner Oliver C, Basaraba Randall J, Belisle John T, Huygen Kris, Orme Ian M
Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Infect Immun. 2003 Apr;71(4):2192-8. doi: 10.1128/IAI.71.4.2192-2198.2003.
The use of DNA constructs encoding mycobacterial proteins is a promising new approach to vaccination against tuberculosis. A DNA vaccine encoding the hsp60 molecule of Mycobacterium leprae has previously been shown to protect against intravenous infection of mice with Mycobacterium tuberculosis in both the prophylactic and immunotherapeutic modes. It is shown here, however, that this vaccine was not effective in a more realistic aerosol infection model or in a model of latent tuberculosis in the lungs. Moreover, when given in an immunotherapeutic model the immunized mice developed classical Koch reactions characterized by multifocal discrete regions of cellular necrosis throughout the lung granulomas. Similar and equally severe reactions were seen in mice given a vaccine with DNA coding for the Ag85 antigen of M. tuberculosis. This previously unanticipated safety problem indicates that DNA vaccines should be used with caution in individuals who may have already been exposed to tuberculosis.
使用编码分枝杆菌蛋白的DNA构建体是一种很有前景的新型结核病疫苗接种方法。先前已证明,编码麻风分枝杆菌hsp60分子的DNA疫苗在预防和免疫治疗模式下均能保护小鼠免受结核分枝杆菌的静脉感染。然而,本文表明,这种疫苗在更现实的气溶胶感染模型或肺部潜伏性结核模型中无效。此外,在免疫治疗模型中给予该疫苗时,免疫小鼠会出现典型的科赫反应,其特征是整个肺肉芽肿中出现多灶性离散的细胞坏死区域。在给予编码结核分枝杆菌Ag85抗原的DNA疫苗的小鼠中也观察到了类似且同样严重的反应。这个先前未预料到的安全问题表明,对于可能已经接触过结核病的个体,应谨慎使用DNA疫苗。